Therapy Areas: Inflammatory Diseases
Boehringer Ingelheim reports strong 2022 performance
30 March 2023 - Germany-based pharmaceutical company Boehringer Ingelheim reported on Wednesday a strong performance in 2022.The company stated that 2022 was a year in which 30 million patients benefi...
Athersys Reports on Type B Meeting with the US FDA
27 March 2023 - - US-based cell therapy and regenerative medicine company Athersys, Inc. (NASDAQ: ATHX) has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B mee...
FSD Pharma's Australian Entity Receives Approval to Proceed with Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder
27 March 2023 - - Canada-based biopharmaceutical company FSD Pharma Inc's (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Australian entity, FSD Pharma Australia Pty Ltd. received the certificate of appro...
Josep Bassaganya-Riera Launches NImmune Biopharma
24 March 2023 - - US-based late-stage precision immunology biopharmaceutical company NImmune Biopharma has launched following the acquisition of omilancor, NIM-1324, and the entire LANCL portfoli...
DIC, Debut Begin Joint Business Development of Polyphenols
22 March 2023 - - Japan-based fine chemicals company DIC Corp has started joint business development in the area of polyphenols with California-based biotech startup Debut, a vertically integrate...
Feinstein Institutes Studies How the Brain and Body Communicate Using Novel Imaging Tech
22 March 2023 - - Bioelectronic medicine researchers at The Feinstein Institutes for Medical Research have developed a new method for studying neural signals transmitted to the brain through...
Related Headlines

Sanofi granted EU approval of Dupixent for young children with severe atopic dermatitis

TFS HealthScience expands into Israel

Ribon Therapeutics Doses First Patient in Phase 1 Clinical Study with RBN-3143 in Patients with Moderate-to-Severe Atopic Dermatitis

Kaufman Named to Abata Therapeutics Board of Directors

United States Specialty Generics Market to Reach USD 43.1bn by 2027, According to Research and Markets

Advanced Infusion Care now offers Kedrion Biopharma infusion therapy GAMMAKED

Can-Fite to provide Namodenoson as compassionate use treatment for decompensated liver cirrhosis patients

Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia

Enthera Pharmaceuticals Initiates Phase 1 Clinical Trial with Lead Candidate Ent001

Sanofi reports Dupixent application for CSU treatment accepted for FDA review

Hansa Biopharma names new chief commercial officer and president of Hansa Biopharma, Inc

OSE Immunotherapeutics announces approval from Spanish Drug Agency for early access program for Tedopi to treat metastatic non-small cell lung cancer

AbbVie's upadacitinib recommended for European regulatory approval to treat adult patients with moderately to severely active Crohn's disease

Incyte Receives Positive CHMP Opinion for Ruxolitinib Cream for the Treatment of Non-segmental Vitiligo in Adults and Adolescents

AbbVie announced receipt of positive CHMP opinion for upadacitinib (RINVOQ) to treat moderate to severe Crohn's disease in adults